News about "Glenmark Therapeutics "

Glenmark Unveils Polyethylene Glycol 3350, Powder for Solution, 17 Grams/Capful

Glenmark Unveils Polyethylene Glycol 3350, Powder for Solution, 17 Grams/Capful

Glenmark Pharmaceuticals is a research-led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on therapeutic areas of respiratory, dermatology and oncology.

Glenmark Therapeutics | 10/03/2025 | By Aishwarya 171

Glenmark Therapeutics Unveils Olopatadine Hydrochloride Ophthalmic Solution

Glenmark Therapeutics Unveils Olopatadine Hydrochloride Ophthalmic Solution

Glenmark Therapeutics has launched Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1 percent (OTC) as compared to the active ingredient in Pataday Twice Daily Relief.

Glenmark Therapeutics | 20/08/2024 | By Aishwarya 160


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members